Product Overview

Alternative Name: Ulipristal acetate (UPA) Oral

Development Status: Active Development

Target: Female

Mode: Hormonal

Delivery Type: Oral

Duration Type: Short-acting

Description: An estrogen-free, daily low dose oral progesterone receptor modulators, ulipristal acetate (UPA).

Updated date: May 30, 2018

Vertical Tabs


Project Phase: Late Development

Project Stage: Phase II

Status Details:
  • A phase II clinical trial is ongoing under the auspices of the NICHD Contraceptive Clinical Trials Network.

Download Product Report